Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Estrogen, HDL, and Coronary Heart Disease in Women

Trial Profile

Estrogen, HDL, and Coronary Heart Disease in Women

Phase of Trial: Phase III

Latest Information Update: 23 Apr 2016

At a glance

  • Drugs Conjugated estrogens (Primary) ; Estradiol congeners; Hormonal replacements; Lipids; Medroxyprogesterone; Progesterone congeners
  • Indications Coronary arteriosclerosis; Menopausal syndrome
  • Focus Pharmacodynamics; Pharmacogenomic
  • Acronyms ERA
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 01 Jul 2009 Results were published in Atherosclerosis.
    • 13 Feb 2008 The expected completion date for this trial is now 1 Feb 2007.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top